Microbot Medical (NASDAQ:MBOT) Bolsa

Microbot Medical

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Pre-Market Outlook

Markets

Movers

ACON

AEON

BCTX

CPHC

EKSO

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

KITT

LDTC

MBOT

MEGL

MNSO

NSTS

SPPL

WFCF

Explora los mayores movimientos en el premercado con ganancias superiores al 100% y pérdidas significativas antes de la apertura.

Acciones de Smart Share Global se disparan un 44%; 20 acciones que se mueven en el premercado

Microbot Medical Inc

SAIH

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

FAMI

BHAT

WKHS

SPGC

ADTX

WLDS

Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) has outperformed the market over the past 5 years by 25.72% on an annualized basis producing an average annual return of 43.07%. Currently, Freeport-McMoRan has a market capitalization of $55.69 billion. 
Buying $1000 In FCX: If an investor had bought $1000 of FCX stock 5 years ago, it would be worth $6,225.96 today based on a price of $38.75 for FCX at the time of writing.
<h3>Freeport-McMoRan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741995909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much You Would Have Made Owning Freeport-McMoRan Stock In The Last 5 Years

PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) has outperformed the market over the past 5 years by 1.09% on an annualized basis producing an average annual return of 18.45%. Currently, PENN Entertainment has a market capitalization of $2.62 billion. 
Buying $100 In PENN: If an investor had bought $100 of PENN stock 5 years ago, it would be worth $200.12 today based on a price of $17.10 for PENN at the time of writing.
<h3>PENN Entertainment's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741995008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PENN

$100 Invested In PENN Entertainment 5 Years Ago Would Be Worth This Much Today

Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) has outperformed the market over the past 10 years by 7.0% on an annualized basis producing an average annual return of 17.38%. Currently, Visa has a market capitalization of $639.27 billion. 
Buying $1000 In V: If an investor had bought $1000 of V stock 10 years ago, it would be worth $4,958.34 today based on a price of $331.40 for V at the time of writing.
<h3>Visa's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741994115_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) has built its reputation on low prices, loyal customers, and a business model that rarely wavers. In a recent interview with <a href="https://chiefexecutive.net/the-costco-way-a-conversation-with-tony-james/">Chief Executive</a> magazine, Chair Hamilton "Tony" James reflected on the late Charlie Munger's deep influence on the company.&nbsp;
Munger, best known as <a href="https://www.benzinga.com/startups/25/02/43451833/warren-buffetts-1m-bet-why-simple-index-funds-crushed-hedge-funds-by-7-1-to-2-2-over-a-decade">Warren Buffett'</a>s longtime partner at Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, BRK.B)), spent over 25 years on Costco's board, pushing a simple but effective message: "Stick to our knitting, our values, and our principles." That philosophy has shaped how the retailer operates to this day.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>
<h2 class="wp-block-heading">Munger's Influence on Costco's Growth</h2>
Munger wasn't just a board member—he was a true believer. He once called himself a "total addict" of the store, adding, "I love everything about Costco. I'm never going to sell a share." And he meant it. <a href="https://www.fool.com/investing/2023/11/01/billionaire-investor-charlie-munger-costco-stock/">The Motley Fool</a> reported his stake in the company was worth over $100 million in 2023.
One of Costco's most famous traditions—the $1.50 hot dog and soda combo—stands as proof of its commitment to keeping prices low. It hasn't changed since 1985, even as costs rise everywhere else.
When former CEO Craig Jelinek suggested raising the price, co-founder Jim Sinegal reportedly shut him down: "If you raise the [price of the] effing hot dog, I will kill you. Figure it out." To save on costs, Costco switched from Coca-Cola to Pepsi in 2013.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
Now, the company plans to bring back Coca-Cola products in its food courts. The company's ability to attract all kinds of shoppers, including wealthy ones, is another reason for its success.&nbsp;
James pointed out that "affluent people love a good deal." That's why Costco stocks luxury items like Rolex watches, Dom Perignon champagne, and 10-carat diamonds. A Porsche dealership in Seattle even displayed cars at a Costco warehouse once, and they sold out in a week.
But not everyone sees Costco's model as foolproof. Some suppliers have complained about its aggressive cost-cutting. A former vendor, in a post on<a href="https://www.reddit.com/r/Costco/comments/istmpc/costco_ruined_my-business_warning-and-rant/"> Reddit</a>, claimed that Costco's pricing demands forced them to slash wages and adopt unsustainable practices.&nbsp;
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Others question how long the company can rely on low-margin goods and membership fees.<a href="https://www.investopedia.com/articles/markets/011216/4-problems-costcos-business-model-cost.asp"> Investopedia</a> notes that this approach could put long-term pressure on earnings.
Recent financial results have also raised concerns. Rising merchandise <a href="https://www.benzinga.com/personal-finance/25/03/44147801/egg-prices-hit-record-4-95-per-dozen-agriculture-secretary-blames-overregulation-for-skyrocketing-cost">costs</a> led Costco to miss profit estimates, <a href="https://www.reuters.com/business/retail-consumer/costco-beats-quarterly-sales-estimates-bulk-buying-surge-2025-03-06/">Reuters</a> reported. Still, the retailer's bulk-selling strategy and loyal customer base keep it strong.
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>

Personal Finance

COST

Why Charlie Munger Never Sold A Single Costco Share—The Billionaire Investor Called Himself A 'Total Addict' Of The Store

Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) has outperformed the market over the past 5 years by 6.68% on an annualized basis producing an average annual return of 24.03%. Currently, Schlumberger has a market capitalization of $55.76 billion. 
Buying $1000 In SLB: If an investor had bought $1000 of SLB stock 5 years ago, it would be worth $2,852.19 today based on a price of $41.00 for SLB at the time of writing.
<h3>Schlumberger's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741993209_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Schlumberger 5 Years Ago Would Be Worth Today

Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) has outperformed the market over the past 10 years by 11.82% on an annualized basis producing an average annual return of 22.21%. Currently, Insulet has a market capitalization of $17.94 billion. 
Buying $100 In PODD: If an investor had bought $100 of PODD stock 10 years ago, it would be worth $743.21 today based on a price of $255.44 for PODD at the time of writing.
<h3>Insulet's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741991416_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PODD

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Tariffs are <a href="https://www.benzinga.com/personal-finance/25/03/44172672/dave-ramsey-says-no-question-tariffs-will-100-raise-prices-walmart-doesnt-pay-taxes-you-pay-taxes-when-you-buy-potato-chips-at-walmart">back in the headlines</a>, and "The Ramsey Show" co-host Ken Coleman isn't having it. In a recent <a href="https://www.youtube.com/watch?v=oODl8YOhtx8">episode</a>, a caller's financial dilemma turned into a fiery discussion on trade wars, economic policy, and why tariffs hit everyday workers harder than politicians like to admit.
The caller, Isaiah from Grand Rapids, Michigan, had been steadily working his way out of debt—following Dave Ramsey's famous Baby Steps—when news of Mexico's retaliation tariffs threw a wrench into his financial plans. His employer, a medical supply company, had already moved production from China to Mexico, and now, with new tariffs in play, they were staring down "significant, significant losses." While leadership hadn't announced layoffs yet, the writing was on the wall.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
</ul>
Isaiah and his wife were on their seventh or eighth week of Financial Peace University and had been making steady progress. They had $51,000 left in debt—a mix of student loans, medical debt, and an old refinance mistake—and were earning $120,000 a year. Their goal? Knock out the remaining balance in two to three years. But with potential job insecurity, Isaiah wasn't sure if they should keep throwing extra cash at debt or pause and build up savings as a safety net.
That's when Coleman jumped in, first digging into the details of the company's situation. Isaiah confirmed that roughly 17% to 18% of their business was affected by imports from Mexico. The problem? The company had fixed contracts in the medical industry—meaning they couldn't simply raise prices to offset the tariff costs. Instead, their profit margins were shrinking, which could lead to budget cuts, layoffs, or worse.
Trending: Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a>
Coleman, a longtime free-trade advocate, didn't hold back:
"That's why guys like me, free traders, I don't like tariffs. Never going to like tariffs. So don't @ me or send me hate email, I'm not going to read it. And I'm right. So we'll just leave it at that. Tariffs become taxes. It's just that simple."
His frustration was clear—this wasn't just political theory; it was real-life economics hitting a caller's paycheck. And Coleman wasn't done. He pointed out that tariffs create a domino effect: businesses struggle, prices go up, wages stagnate, and in some cases, people lose their jobs.
But what about Isaiah's original question? Should he pause his debt payoff plan?
Co-host George Kamel stepped in with a measured response:
<ul>
<li>No, don't pause just yet. There wasn't enough concrete evidence that layoffs were imminent.</li>
<li>Yes, stay alert. Keep an eye on company updates, and if job cuts start looking inevitable, then it might be time to hit pause and stack up cash.</li>
<li>Consider a backup plan. Isaiah's skills were in demand, so it might be smart to start looking for other job opportunities in case things went south.</li>
</ul>
That's when the conversation took a broader turn into headlines vs. guidelines.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Coleman warned against reacting emotionally to news cycles, pointing out that media headlines thrive on fear—whether it's a 900-point stock market drop, trade war speculation, or recession predictions. Instead, he urged listeners to focus on guidelines—financial principles that keep people secure no matter what's happening in the economy. He added, "The stuff that we teach makes you recession-proof."&nbsp;
The segment wrapped with a blunt reality check: if the government is going to impose tariffs, they need to also deregulate and cut business taxes so companies can <a href="https://www.benzinga.com/personal-finance/25/03/44227970/from-cars-to-avocados-whats-spared-in-trumps-tariff-pause">afford to produce goods domestically</a>. Otherwise, the result is exactly what Isaiah was experiencing—businesses caught in the crossfire, scrambling to cover costs, and employees left wondering if they'll have a job tomorrow.
Read Next:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>

'Tariffs Become Taxes' — Ramsey Host Warns of Trade War Fallout as Medical Worker Worries Mexico's Retaliation Tariffs Could Put His Job at Risk

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has outperformed the market over the past 20 years by 5.78% on an annualized basis producing an average annual return of 13.96%. Currently, FactSet Research Systems has a market capitalization of $16.61 billion. 
Buying $1000 In FDS: If an investor had bought $1000 of FDS stock 20 years ago, it would be worth $13,318.60 today based on a price of $436.85 for FDS at the time of writing.
<h3>FactSet Research Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741989638_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In FactSet Research Systems 20 Years Ago Would Be Worth Today

Harold Hamm, oil magnate and founder of Continental Resources, issued a stark warning: if oil prices remain at current levels, drilling in key U.S. shale fields could <a href="https://www.benzinga.com/25/03/44168987/oil-prices-hit-multi-year-lows">come to a standstill. </a>
The Details: Speaking at CERAWeek in Houston, Hamm emphasized that with oil prices hovering near $65 per barrel, many fields are already struggling to remain viable.&nbsp;
"When you get below the cost of supply, you can't ‘drill, baby, drill,'" he told Bloomberg, per OilPrice.com.
Read Next: <a href="https://www.benzinga.com/government/regulations/25/03/44310724/doge-cuts-to-ftc-sow-confusion-in-case-against-amazon">DOGE Cuts To FTC Sow Confusion In Case Against Amazon</a>&nbsp;
While industry leaders have applauded the rollback of Biden-era climate regulations, Trump's trade policies—particularly his tariff disputes with Canada—are creating uncertainty and further pressuring crude oil prices. Trump has described the lower prices as "phenomenal news," but many in the oil sector are expressing concern.&nbsp;
"There are a lot of fields that are getting to the point that's real tough to keep that cost of supply down," Hamm told Bloomberg Television.&nbsp;
"When you get down to that $50 oil that you talked about, then you're below the point where you're going to ‘drill, baby, drill.'"
ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) CEO Ryan Lance also highlighted inflationary pressures and investor anxiety over Trump's unpredictable trade policies affecting the industry.&nbsp;
Scott Sheffield, former CEO of Pioneer Natural Resources, told Bloomberg Television that the price publicly traded oil drillers need to cover costs and turn a profit is between $50 and $55 a barrel. 
The oil industry could be at a turning point as low oil prices benefit consumers but pose significant challenges for producers. 
The United States Oil Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) ETF, tracking the daily price movements of light, sweet crude oil, is down more than 4% in 2025. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44253259/uncertainty-rocks-the-trump-trade-how-maga-seven-stocks-look-now">Uncertainty Rocks The Trump Trade: How &#8216;MAGA Seven&#8217; Stocks Look Now</a></li>
</ul>
Image: Shutterstock&nbsp;

Specialty ETFs

Commodities

Management

ETFs

Oil Titan Harold Hamm Warns Drilling Could Stop If Oil Prices Remain Low: 'You Can't Drill, Baby, Drill'

Castellum, Inc. (the "Company" or "Castellum") (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, today announced that it intends to offer and sell shares of its common stock and warrants exercisable into shares of the Company's common stock, in a public offering. All of the shares of common stock are being offered by Castellum. Castellum initially intends to use the net proceeds of the offering for working capital and general corporate purposes. Consummation of the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Maxim Group LLC is acting as the sole placement agent for the offering on a reasonable best-efforts basis.

Offerings

Castellum Announces Proposed Public Offering Of Common Stock And Warrants; No Size Or Amount Disclosed

Simon Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPG#NYSE">SPG</a>) has outperformed the market over the past 5 years by 4.97% on an annualized basis producing an average annual return of 22.32%. Currently, Simon Property Group has a market capitalization of $52.60 billion. 
Buying $1000 In SPG: If an investor had bought $1000 of SPG stock 5 years ago, it would be worth $2,450.37 today based on a price of $161.21 for SPG at the time of writing.
<h3>Simon Property Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741988720_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Simon Property Group Stock In The Last 5 Years

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 11.68% on an annualized basis producing an average annual return of 22.06%. Currently, Meta Platforms has a market capitalization of $1.54 trillion. 
Buying $1000 In META: If an investor had bought $1000 of META stock 10 years ago, it would be worth $7,509.58 today based on a price of $607.60 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741987839_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) has outperformed the market over the past 10 years by 10.63% on an annualized basis producing an average annual return of 21.02%. Currently, GoDaddy has a market capitalization of $24.90 billion. 
Buying $100 In GDDY: If an investor had bought $100 of GDDY stock 10 years ago, it would be worth $673.61 today based on a price of $176.15 for GDDY at the time of writing.
<h3>GoDaddy's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741986909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GDDY

Here's How Much You Would Have Made Owning GoDaddy Stock In The Last 10 Years

Financing

Press Releases

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors

Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®

General

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $13 Million Registered Direct Offering

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

HeartBeam

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Edap TMS

Femasys

Fractyl Health

Hyperfine

Monogram Technologies Inc. - Common Stock

Monogram Technologies

Milestone Scientific

Modular Medical

NanoVibronix

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Nexalin Technology

Owlet

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

Sensus Healthcare

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Vivani Medical

Beyond Air

HC Wainwright & Co.

Screenshot 2024-12-13 at 6.45.20 PM

Biotech

Advanced Robotics Are Reshaping Medicine

Untitled design - 2024-12-10T185819.364

Health Care

Movers & Shakers

ISRG

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics

Comments

Microbot Medical

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL